The clinical landscape of bladder cancer treatment: a brief report on new developments and future perspectives in pharmaceutical interventions
The results demonstrate that the overall number of clinical trials has tended to increase, with a subsequent decline observed in the post-COVID-19 period; the United States has led research efforts, followed by China, the United Kingdom, Canada, and Australia; the therapeutic focus has shifted from traditional chemothe...